Back to Search Start Over

Effects of low temperature on blood-to-plasma ratio measurement.

Authors :
Novak JJ
Burchett W
Di L
Source :
Biopharmaceutics & drug disposition [Biopharm Drug Dispos] 2021 May; Vol. 42 (5), pp. 234-241. Date of Electronic Publication: 2021 Mar 15.
Publication Year :
2021

Abstract

The blood-to-plasma ratio (R <subscript>b</subscript> ) is an important property of drug candidates. R <subscript>b</subscript> is applied widely in drug discovery to convert plasma pharmacokinetic parameters to the respective parameters in blood and to develop in vitro-in vivo correlations. Some compounds such as prodrugs, soft drugs, and peptide mimetics are unstable in blood, making accurate in vitro R <subscript>b</subscript> measurement challenging, but necessary. Low temperature often reduces the rate of enzymatic and chemical reactions and increases the stability of labile compounds in biomatrices. In this study, the effects of 4°C on R <subscript>b</subscript> measurement were evaluated using a set of structurally diverse compounds with various binding and red blood cell (RBC) transport mechanisms. The results indicate that a 4°C R <subscript>b</subscript> method provides comparable R <subscript>b</subscript> values to the 37°C method for most compounds and can therefore be applied to measure the R <subscript>b</subscript> of unstable compounds in drug discovery. In some rare cases, when compounds have a high affinity to specific RBC components (e.g., carbonic anhydrase), the 4°C method may underestimate R <subscript>b.</subscript> In these specific cases, the use of appropriate inhibitors to stabilize unstable compounds is recommended.<br /> (© 2021 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1099-081X
Volume :
42
Issue :
5
Database :
MEDLINE
Journal :
Biopharmaceutics & drug disposition
Publication Type :
Academic Journal
Accession number :
33625733
Full Text :
https://doi.org/10.1002/bdd.2265